{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:37:30Z","timestamp":1783463850933,"version":"3.55.0"},"reference-count":100,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T00:00:00Z","timestamp":1444003200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00005-015-0361-y","type":"journal-article","created":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T14:42:09Z","timestamp":1444056129000},"page":"127-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Immunopathogenic Background of Pars Planitis"],"prefix":"10.2478","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1099-4876","authenticated-orcid":false,"given":"Joanna","family":"Prze\u017adziecka-Do\u0142yk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Turno-Kr\u0119cicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Misiuk-Hoj\u0142o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2015,10,5]]},"reference":[{"key":"361_CR1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1076\/ocii.10.2.117.13980","volume":"10","author":"AM Abu El-Asrar","year":"2002","unstructured":"Abu El-Asrar AM, Geboes K (2002) An immunohistochemical study of the \u201csnowbank\u201d in a case of pars planiti. Ocul Immunol Inflamm 10:117\u2013123","journal-title":"Ocul Immunol Inflamm"},{"issue":"303\u2013309","key":"361_CR2","first-page":"e2","volume":"148","author":"NR Acharya","year":"2009","unstructured":"Acharya NR, Hong KC, Lee SM (2009) Ranibizumab for refractory uveitis-related macular edema. Am J Ophthalmol 148(303\u2013309):e2","journal-title":"Am J Ophthalmol"},{"key":"361_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/08830180212068","volume":"21","author":"G Adamus","year":"2002","unstructured":"Adamus G, Chan CC (2002) Experimental autoimmune uveitides: multiple antigens, diverse diseases. Int Rev Immunol 21:209\u2013229","journal-title":"Int Rev Immunol"},{"key":"361_CR4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0165-5728(00)00252-6","volume":"108","author":"G Adamus","year":"2000","unstructured":"Adamus G, Manczak M, Sugden B et al (2000) Epitope recognition and T cell receptors in recurrent autoimmune anterior uveitis in Lewis rats immunized with myelin basic protein. J Neuroimmunol 108:122\u2013130","journal-title":"J Neuroimmunol"},{"key":"361_CR5","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.4049\/jimmunol.175.9.6133","volume":"175","author":"JK Ahn","year":"2005","unstructured":"Ahn JK, Chung H, Lee D et al (2005) CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behcet\u2019s uveitis. J Immunol 175:6133\u20136142","journal-title":"J Immunol"},{"key":"361_CR6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0198-8859(03)00185-X","volume":"64","author":"C Alaez","year":"2003","unstructured":"Alaez C, Arellanes L, Vazquez A et al (2003) Classic Pars Planitis: strong correlation of class II genes with gender and some clinical features in Mexican Mestizos. Hum Immunol 64:965\u2013972","journal-title":"Hum Immunol"},{"key":"361_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/0301-4738.58469","volume":"58","author":"BM Babu","year":"2010","unstructured":"Babu BM, Rathinam SR (2010) Intermediate uveitis. Indian J Ophthalmol 58:21\u201327","journal-title":"Indian J Ophthalmol"},{"key":"361_CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1212\/WNL.28.9_Part_2.119","volume":"28","author":"CR Bamford","year":"1978","unstructured":"Bamford CR, Ganley JP, Sibley WA et al (1978) Uveitis, perivenous sheathing and multiple sclerosis. Neurology 28:119\u2013124","journal-title":"Neurology"},{"key":"361_CR9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/cimm.1995.1152","volume":"164","author":"K Barton","year":"1995","unstructured":"Barton K, McLauchlan MT, Calder VL et al (1995) The kinetics of cytokine mRNA expression in the retina during experimental autoimmune uveoretinitis. Cell Immunol 164:133\u2013140","journal-title":"Cell Immunol"},{"key":"361_CR10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","volume":"103","author":"E Bloch-Michel","year":"1987","unstructured":"Bloch-Michel E, Nussenblatt RB (1987) International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103:234\u2013235","journal-title":"Am J Ophthalmol"},{"key":"361_CR11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archopht.1968.00980050749013","volume":"80","author":"RJ Brockhurst","year":"1968","unstructured":"Brockhurst RJ, Schepens CL (1968) Uveitis. IV. Peripheral uveitis: the complications of retinal detachment. Arch Ophthalmol 80:747\u2013753","journal-title":"Arch Ophthalmol"},{"key":"361_CR12","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.4049\/jimmunol.161.4.2052","volume":"161","author":"AC Buenafe","year":"1998","unstructured":"Buenafe AC, Offner H, Machnicki M et al (1998) EAE TCR motifs and antigen recognition in myelin basic protein-induced anteri or uveitis in Lewis rats. J Immunol 161:2052\u20132059","journal-title":"J Immunol"},{"key":"361_CR13","first-page":"2019","volume":"40","author":"VL Calder","year":"1999","unstructured":"Calder VL, Shaer B, Muhaya M et al (1999) Increased CD4+ expression and decreased IL-10 in the anterior chamber in idiopathic uveitis. Invest Ophthalmol Vis Sci 40:2019\u20132024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0090-1229(85)90083-2","volume":"35","author":"CC Chan","year":"1985","unstructured":"Chan CC, Mochizuki M, Nussenblatt RB et al (1985a) T-lymphocyte subsets in experimental autoimmune uveitis. Clin Immunol Immunopathol 35:103\u2013110","journal-title":"Clin Immunol Immunopathol"},{"key":"361_CR15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0008-8749(85)90373-9","volume":"96","author":"CC Chan","year":"1985","unstructured":"Chan CC, Mochizuki M, Palestine AG et al (1985b) Kinetics of T-lymphocyte subsets in the eyes of Lewis rats with experimental autoimmune uveitis. Cell Immunol 96:430\u2013434","journal-title":"Cell Immunol"},{"key":"361_CR16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3129\/i07-159","volume":"42","author":"SM Chan","year":"2007","unstructured":"Chan SM, Hudson M, Weis E (2007) Anterior and intermediate uveitis cases referred to a tertiary centre in Alberta. Can J Ophthalmol 42:860\u2013864","journal-title":"Can J Ophthalmol"},{"key":"361_CR17","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1167\/iovs.05-0444","volume":"46","author":"SJ Curnow","year":"2005","unstructured":"Curnow SJ, Falciani F, Durrani OM et al (2005) Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci 46:4251\u20134259","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR18","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/eji.1830240707","volume":"24","author":"AD D\u2019Angeac","year":"1994","unstructured":"D\u2019Angeac AD, Monier S, Pilling D et al (1994) CD57+ T lymphocytes are derived from CD57\u2212 precursors by differentiation occurring in late immune responses. Eur J Immunol 24:1503\u20131511","journal-title":"Eur J Immunol"},{"key":"361_CR19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000429632","volume":"23","author":"JL Davis","year":"1992","unstructured":"Davis JL, Chan CC, Nussenblatt RB (1992) Immunology of intermediate uveitis. Dev Ophthalmol 23:71\u201385","journal-title":"Dev Ophthalmol"},{"key":"361_CR20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/02713688108998359","volume":"1","author":"Y Kozak De","year":"1981","unstructured":"De Kozak Y, Sakai J, Thillaye B et al (1981) S antigen-induced experimental autoimmune uveo-retinitis in rats. Curr Eye Res 1:327\u2013337","journal-title":"Curr Eye Res"},{"key":"361_CR21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0420.1997.tb00256.x","volume":"75","author":"JS Deane","year":"1997","unstructured":"Deane JS, Rosenthal AR (1997) Course and complications of intermediate uveitis. Acta Ophthalmol Scand 75:82\u201384","journal-title":"Acta Ophthalmol Scand"},{"key":"361_CR22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bjo.72.2.83","volume":"72","author":"J Desch\u00eanes","year":"1988","unstructured":"Desch\u00eanes J, Char DH, Kaleta S (1988) Activated T lymphocytes in uveitis. Br J Ophthalmol 72:83\u201387","journal-title":"Br J Ophthalmol"},{"issue":"Pt 6","key":"361_CR23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/eye.1992.138","volume":"6","author":"AD Dick","year":"1992","unstructured":"Dick AD, Cheng YF, Purdie AT et al (1992) Immunocytochemical analysis of blood lymphocytes in uveitis. Eye 6(Pt 6):643\u2013647","journal-title":"Eye"},{"key":"361_CR24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1006\/exer.1997.0359","volume":"65","author":"JE Dickerson","year":"1997","unstructured":"Dickerson JE, Dotzel E, Clark AF (1997) Steroid-induced cataract: new perspective from in vitro and lens culture studies. Exp Eye Res 65:507\u2013516","journal-title":"Exp Eye Res"},{"key":"361_CR25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ajo.2007.08.023","volume":"144","author":"MJ Donaldson","year":"2007","unstructured":"Donaldson MJ, Pulido JS, Herman DC et al (2007) Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol 144:812\u2013817","journal-title":"Am J Ophthalmol"},{"key":"361_CR26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00417-007-0539-z","volume":"245","author":"D Doycheva","year":"2007","unstructured":"Doycheva D, Deshka D, Preuss B et al (2007) High incidence of antibodies to lens proteins in sera from patients with uveitis. Graefes Arch Clin Exp Ophthalmol 245:683\u2013688","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"361_CR27","first-page":"164","volume":"64","author":"JW Eichenbaum","year":"1988","unstructured":"Eichenbaum JW, Friedman AH, Mamelok AE (1988) A clinical and histopathological review of intermediate uveitis (\u201cpars planitis\u201d). Bull N Y Acad Med 64:164\u2013174","journal-title":"Bull N Y Acad Med"},{"key":"361_CR28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archopht.1982.01030030754006","volume":"100","author":"KS Felder","year":"1982","unstructured":"Felder KS, Brockhurst RJ (1982) Neovascular fundus abnormalities in peripheral uveitis. Arch Ophthalmol 100:750\u2013754","journal-title":"Arch Ophthalmol"},{"key":"361_CR29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2249.1995.tb05566.x","volume":"99","author":"EJ Feron","year":"1995","unstructured":"Feron EJ, Calder VL, Lightman SL (1995) Oligoclonal activation of CD4+\u00a0T lymphocytes in posterior uveitis. Clin Exp Immunol 99:412\u2013418","journal-title":"Clin Exp Immunol"},{"key":"361_CR30","doi-asserted-by":"crossref","DOI":"10.5005\/jp\/books\/11822","volume-title":"Diagnosis and treatment of uveitis","author":"CS Foster","year":"2013","unstructured":"Foster CS, Vitale AT (2013) Diagnosis and treatment of uveitis, 2nd edn. Jaypee Brothers Medical Publishers, New Delhi","edition":"2"},{"key":"361_CR31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S0004-27492012000200016","volume":"75","author":"F Gasparin","year":"2012","unstructured":"Gasparin F, Takahashi BS, Scolari MR et al (2012) Experimental models of autoimmune inflammatory ocular diseases. Arq Bras Oftalmol 75:143\u2013147","journal-title":"Arq Bras Oftalmol"},{"key":"361_CR32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0002-9394(70)90661-6","volume":"70","author":"CL Giles","year":"1970","unstructured":"Giles CL (1970) Peripheral uveitis in patients with multiple sclerosis. Am J Ophthalmol 70:17\u201319","journal-title":"Am J Ophthalmol"},{"issue":"Pt 3","key":"361_CR33","first-page":"361","volume":"101","author":"WR Green","year":"1981","unstructured":"Green WR, Kincaid MC, Michels RG et al (1981) Pars planitis. Trans Ophthalmol Soc UK 101(Pt 3):361\u2013367","journal-title":"Trans Ophthalmol Soc UK"},{"key":"361_CR34","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1167\/iovs.07-0286","volume":"48","author":"DS Gregerson","year":"2007","unstructured":"Gregerson DS, Heuss ND, Lew KL et al (2007) Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy. Invest Ophthalmol Vis Sci 48:4654\u20134663","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/112067210301300503","volume":"13","author":"KH Greiner","year":"2003","unstructured":"Greiner KH, Wilson DW, Thomson J et al (2003) Genetic polymorphism of HLA DR in a Scottish population of patients with pars planitis. Eur J Ophthalmol 13:433\u2013438","journal-title":"Eur J Ophthalmol"},{"key":"361_CR36","doi-asserted-by":"crossref","unstructured":"Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in Northern California; the Northern California epidemiology of uveitis study. Ophthalmology 111:491\u2013500 (discussion 500)","DOI":"10.1016\/j.ophtha.2003.06.014"},{"key":"361_CR37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.exer.2008.04.003","volume":"88","author":"V Gupta","year":"2009","unstructured":"Gupta V, Wagner BJ (2009) Search for a functional glucocorticoid receptor in the mammalian lens. Exp Eye Res 88:248\u2013256","journal-title":"Exp Eye Res"},{"key":"361_CR38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0002-9394(14)74217-5","volume":"103","author":"DE Henderly","year":"1987","unstructured":"Henderly DE, Genstler AJ, Smith RE et al (1987) Changing patterns of uveitis. Am J Ophthalmol 103:131\u2013136","journal-title":"Am J Ophthalmol"},{"key":"361_CR39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0404.1996.tb07047.x","volume":"94","author":"J Hillert","year":"1996","unstructured":"Hillert J, K\u00e4ll T, Olerup O et al (1996) Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity. Acta Neurol Scand 94:161\u2013166","journal-title":"Acta Neurol Scand"},{"key":"361_CR40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1076\/ocii.11.2.91.15914","volume":"11","author":"K Ishida","year":"2003","unstructured":"Ishida K, Panjwani N, Cao Z et al (2003) Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms. Ocul Immunol Inflamm 11:91\u2013105","journal-title":"Ocul Immunol Inflamm"},{"key":"361_CR41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509\u2013516","journal-title":"Am J Ophthalmol"},{"key":"361_CR42","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1167\/iovs.03-0401","volume":"44","author":"ER James","year":"2003","unstructured":"James ER, Robertson L, Ehlert E et al (2003) Presence of a transcriptionally active glucocorticoid receptor alpha in lens epithelial cells. Invest Ophthalmol Vis Sci 44:5269\u20135276","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR43","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.preteyeres.2008.09.003","volume":"27","author":"C Kaur","year":"2008","unstructured":"Kaur C, Foulds WS, Ling EA (2008) Blood\u2013retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res 27:622\u2013647","journal-title":"Prog Retin Eye Res"},{"key":"361_CR44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/bjo.2006.099192","volume":"91","author":"H Keino","year":"2007","unstructured":"Keino H, Takeuchi M, Usui Y et al (2007) Supplementation of CD4+\u00a0CD25+\u00a0regulatory T cells suppresses experimental autoimmune uveoretinitis. Br J Ophthalmol 91:105\u2013110","journal-title":"Br J Ophthalmol"},{"key":"361_CR45","first-page":"391","volume":"95","author":"KR Kenyon","year":"1975","unstructured":"Kenyon KR, Pederson JE, Green WR et al (1975) Fibroglial proliferation in pars planitis. Trans Ophthalmol Soc UK 95:391\u2013397","journal-title":"Trans Ophthalmol Soc UK"},{"key":"361_CR46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.preteyeres.2008.07.001","volume":"27","author":"EC Kerr","year":"2008","unstructured":"Kerr EC, Copland DA, Dick AD et al (2008) The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis. Prog Retin Eye Res 27:527\u2013535","journal-title":"Prog Retin Eye Res"},{"key":"361_CR47","first-page":"1285","volume":"42","author":"DJ Kilmartin","year":"2001","unstructured":"Kilmartin DJ, Fletcher ZJ, Almeida JA et al (2001) CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis. Invest Ophthalmol Vis Sci 42:1285\u20131292","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR48","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/bjo.82.8.871","volume":"82","author":"AM Klok","year":"1998","unstructured":"Klok AM, Luyendijk L, Zaal MJ et al (1998) Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis. Br J Ophthalmol 82:871\u2013874","journal-title":"Br J Ophthalmol"},{"key":"361_CR49","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/bjo.83.7.847","volume":"83","author":"AM Klok","year":"1999","unstructured":"Klok AM, Luyendijk L, Zaal MJ et al (1999) Soluble ICAM-1 serum levels in patients with intermediate uveitis. Br J Ophthalmol 83:847\u2013851","journal-title":"Br J Ophthalmol"},{"key":"361_CR50","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1167\/iovs.07-0112","volume":"48","author":"EC Leal","year":"2007","unstructured":"Leal EC, Manivannan A, Hosoya KI et al (2007) Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood\u2013retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 48:5257\u20135265","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR51","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0014-4835(05)80056-9","volume":"61","author":"Q Li","year":"1995","unstructured":"Li Q, Peng B, Whitcup SM et al (1995) Endotoxin induced uveitis in the mouse: susceptibility and genetic control. Exp Eye Res 61:629\u2013632","journal-title":"Exp Eye Res"},{"key":"361_CR52","doi-asserted-by":"crossref","unstructured":"Malinowski SM, Pulido JS, Folk JC (1993a) Long-term visual outcome and complications associated with pars planitis. Ophthalmology 100:818\u2013824 (discussion 825)","DOI":"10.1016\/S0161-6420(93)31567-8"},{"key":"361_CR53","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0161-6420(93)31505-8","volume":"100","author":"SM Malinowski","year":"1993","unstructured":"Malinowski SM, Pulido JS, Goeken NE et al (1993b) The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology 100:1199\u20131205","journal-title":"Ophthalmology"},{"key":"361_CR54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.medcli.2010.02.029","volume":"135","author":"ME Mantrana-Bermejo","year":"2010","unstructured":"Mantrana-Bermejo ME, Rueda-Rueda T, Bernabeu-Wittel J et al (2010) Clinical and epidemiological features and HLA association in patients with pars planitis. Med Cl\u00ednica 135:205\u2013208","journal-title":"Med Cl\u00ednica"},{"key":"361_CR55","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ajo.2004.09.058","volume":"139","author":"NN Markomichelakis","year":"2005","unstructured":"Markomichelakis NN, Theodossiadis PG, Sfikakis PP (2005) Regression of neovascular age-related macular degeneration following infliximab therapy. Am J Ophthalmol 139:537\u2013540","journal-title":"Am J Ophthalmol"},{"key":"361_CR56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/jaut.1999.0319","volume":"13","author":"DM Matteson","year":"1999","unstructured":"Matteson DM, Shen DF, Chan CC (1999) Inhibition of experimental melanin protein-induced uveitis (EMIU) by targeting nitric oxide via phosphatidylcholine-specific phospholipase C. J Autoimmun 13:197\u2013204","journal-title":"J Autoimmun"},{"key":"361_CR57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9394(14)70532-X","volume":"121","author":"CA McCannel","year":"1996","unstructured":"McCannel CA, Holland GN, Helm CJ et al (1996) Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 121:35\u201346","journal-title":"Am J Ophthalmol"},{"key":"361_CR58","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bjo.2003.028506","volume":"88","author":"CC Murphy","year":"2004","unstructured":"Murphy CC, Duncan L, Forrester JV et al (2004) Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis. Br J Ophthalmol 88:412\u2013416","journal-title":"Br J Ophthalmol"},{"key":"361_CR59","volume-title":"Uveitis: fundamentals and clinical practice","author":"RB Nussenblatt","year":"1989","unstructured":"Nussenblatt RB, Palestine AG (1989) Uveitis: fundamentals and clinical practice. Year Book Medical Publishers, Chicago"},{"key":"361_CR60","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0002-9394(00)00863-1","volume":"131","author":"S Oruc","year":"2001","unstructured":"Oruc S, Duffy BF, Mohanakumar T et al (2001) The association of HLA class II with pars planitis. Am J Ophthalmol 131:657\u2013659","journal-title":"Am J Ophthalmol"},{"key":"361_CR61","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0002-9394(78)90118-6","volume":"86","author":"JE Pederson","year":"1978","unstructured":"Pederson JE, Kenyon KR, Green WR et al (1978) Pathology of pars planitis. Am J Ophthalmol 86:762\u2013774","journal-title":"Am J Ophthalmol"},{"key":"361_CR62","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/bjo.2007.116277","volume":"91","author":"M Pedroza-Seres","year":"2007","unstructured":"Pedroza-Seres M, Linares M, Voorduin S et al (2007) Pars planitis is associated with an increased frequency of effector-memory CD57+ T cells. Br J Ophthalmol 91:1393\u20131398","journal-title":"Br J Ophthalmol"},{"key":"361_CR63","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1167\/iovs.06-1189","volume":"48","author":"Y Peng","year":"2007","unstructured":"Peng Y, Shao H, Ke Y et al (2007) Minimally activated CD8 autoreactive T cells specific for IRBP express a high level of Foxp3 and are functionally suppressive. Invest Ophthalmol Vis Sci 48:2178\u20132184","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR64","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/bjo.56.6.478","volume":"56","author":"R Porter","year":"1972","unstructured":"Porter R (1972) Uveitis in association with multiple sclerosis. Br J Ophthalmol 56:478\u2013481","journal-title":"Br J Ophthalmol"},{"key":"361_CR65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1076\/ocii.9.2.93.3975","volume":"9","author":"JF Prieto","year":"2001","unstructured":"Prieto JF, Dios E, Gutierrez JM et al (2001) Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm 9:93\u2013102","journal-title":"Ocul Immunol Inflamm"},{"key":"361_CR66","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2003.12.010","volume":"137","author":"K Probst","year":"2004","unstructured":"Probst K, Fijnheer R, Rothova A (2004) Endothelial cell activation and hypercoagulability in ocular Beh\u00e7et\u2019s disease. Am J Ophthalmol 137:850\u2013857","journal-title":"Am J Ophthalmol"},{"key":"361_CR67","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0002-9394(74)90452-8","volume":"77","author":"RC Pruett","year":"1974","unstructured":"Pruett RC, Brockhurst J, Letts NF (1974) Fluorescein angiography of peripheral uveitis. Am J Ophthalmol 77:448\u2013453","journal-title":"Am J Ophthalmol"},{"key":"361_CR68","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0161-6420(99)90122-7","volume":"106","author":"SC Raja","year":"1999","unstructured":"Raja SC, Jabs DA, Dunn JP et al (1999) Pars planitis: clinical features and class II HLA associations. Ophthalmology 106:594\u2013599","journal-title":"Ophthalmology"},{"key":"361_CR69","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3109\/02713689509000004","volume":"4","author":"FG Roberge","year":"1985","unstructured":"Roberge FG, Caspi RR, Chan CC et al (1985) Long-term culture of Muller cells from adult rats in the presence of activated lymphocytes\/monocytes products. Curr Eye Res 4:975\u2013982","journal-title":"Curr Eye Res"},{"key":"361_CR70","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archopht.1996.01100130585016","volume":"114","author":"A Rodriguez","year":"1996","unstructured":"Rodriguez A, Calonge M, Pedroza-Seres M et al (1996) Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 114:593\u2013599","journal-title":"Arch Ophthalmol"},{"key":"361_CR71","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nri3391","volume":"13","author":"R Shechter","year":"2013","unstructured":"Shechter R, London A, Schwartz M (2013) Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol 13:206\u2013218","journal-title":"Nat Rev Immunol"},{"key":"361_CR72","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00417-006-0356-9","volume":"245","author":"K Siepmann","year":"2007","unstructured":"Siepmann K, Biester S, Plskov\u00e1 J et al (2007) CD4+CD25+\u00a0T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo. Graefes Arch Clin Exp Ophthalmol 245:221\u2013229","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"361_CR73","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.4049\/jimmunol.179.8.5146","volume":"179","author":"PB Silver","year":"2007","unstructured":"Silver PB, Agarwal RK, Su SB et al (2007) Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells. J Immunol 179:5146\u20135158","journal-title":"J Immunol"},{"key":"361_CR74","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0002-9394(76)90434-7","volume":"82","author":"RE Smith","year":"1976","unstructured":"Smith RE, Godfrey WA, Kimura SJ (1976) Complications of chronic cyclitis. Am J Ophthalmol 82:277\u2013282","journal-title":"Am J Ophthalmol"},{"key":"361_CR75","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1167\/iovs.01-1261","volume":"44","author":"D Stempel","year":"2003","unstructured":"Stempel D, Sandusky H, Lampi K et al (2003) BetaB 1-crystallin: identification of a candidate ciliary body uveitis antigen. Invest Ophthalmol Vis Sci 44:203\u2013209","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR76","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nri1224","volume":"3","author":"JW Streilein","year":"2003","unstructured":"Streilein JW (2003) Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 3:879\u2013889","journal-title":"Nat Rev Immunol"},{"key":"361_CR77","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00005-009-0030-0","volume":"57","author":"S Sugita","year":"2009","unstructured":"Sugita S (2009) Role of ocular pigment epithelial cells in immune privilege. Arch Immunol Ther Exp 57:263\u2013268","journal-title":"Arch Immunol Ther Exp"},{"key":"361_CR78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1084\/jem.20030097","volume":"198","author":"S Sugita","year":"2003","unstructured":"Sugita S, Streilein JW (2003) Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med 198:161\u2013171","journal-title":"J Exp Med"},{"key":"361_CR79","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.4049\/jimmunol.172.7.4184","volume":"172","author":"S Sugita","year":"2004","unstructured":"Sugita S, Ng TF, Schwartzkopff J et al (2004) CTLA-4+CD8+\u00a0T cells that encounter B7.2+\u00a0iris pigment epithelial cells express their own B7.2 to achieve global suppression of T cell activation. J Immunol 172:4184\u20134194","journal-title":"J Immunol"},{"key":"361_CR80","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.exer.2006.08.005","volume":"83","author":"S Sugita","year":"2006","unstructured":"Sugita S, Futagami Y, Smith SB et al (2006a) Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta. Exp Eye Res 83:1459\u20131471","journal-title":"Exp Eye Res"},{"key":"361_CR81","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1167\/iovs.05-1354","volume":"47","author":"S Sugita","year":"2006","unstructured":"Sugita S, Keino H, Futagami Y et al (2006b) B7+\u00a0iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells. Invest Ophthalmol Vis Sci 47:5376\u20135384","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR82","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4049\/jimmunol.176.1.118","volume":"176","author":"S Sugita","year":"2006","unstructured":"Sugita S, Ng TF, Lucas PJ et al (2006c) B7+ iris pigment epithelium induce CD8+ T regulatory cells; both suppress CTLA-4+\u00a0T cells. J Immunol 176:118\u2013127","journal-title":"J Immunol"},{"key":"361_CR83","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.4049\/jimmunol.181.11.7525","volume":"181","author":"S Sugita","year":"2008","unstructured":"Sugita S, Horie S, Nakamura O et al (2008) Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells. J Immunol 181:7525\u20137536","journal-title":"J Immunol"},{"key":"361_CR84","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.4049\/jimmunol.0901623","volume":"183","author":"S Sugita","year":"2009","unstructured":"Sugita S, Horie S, Nakamura O et al (2009) Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2alpha during inflammatory conditions. J Immunol 183:5013\u20135022","journal-title":"J Immunol"},{"key":"361_CR85","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1167\/iovs.09-5098","volume":"51","author":"S Sugita","year":"2010","unstructured":"Sugita S, Horie S, Yamada Y et al (2010) Inhibition of B-cell activation by retinal pigment epithelium. Invest Ophthalmol Vis Sci 51:5783\u20135788","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR86","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10384-011-0064-9","volume":"55","author":"S Sugita","year":"2011","unstructured":"Sugita S, Horie S, Yamada Y et al (2011) Suppression of interleukin-17-producing T-helper 17 cells by retinal pigment epithelial cells. Jpn J Ophthalmol 55:565\u2013575","journal-title":"Jpn J Ophthalmol"},{"key":"361_CR87","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1167\/iovs.12-11483","volume":"54","author":"S Sugita","year":"2013","unstructured":"Sugita S, Kawazoe Y, Imai A et al (2013a) Mature dendritic cell suppression by IL-1 receptor antagonist on retinal pigment epithelium cells. Invest Ophthalmol Vis Sci 54:3240\u20133249","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR88","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1167\/iovs.13-12703","volume":"54","author":"S Sugita","year":"2013","unstructured":"Sugita S, Kawazoe Y, Imai A et al (2013b) Suppression of IL-22-producing T helper 22 cells by RPE cells via PD-L1\/PD-1 interactions. Invest Ophthalmol Vis Sci 54:6926\u20136933","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR89","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9394(14)70994-8","volume":"123","author":"WM Tang","year":"1997","unstructured":"Tang WM, Pulido JS, Eckels DD et al (1997) The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol 123:70\u201375","journal-title":"Am J Ophthalmol"},{"key":"361_CR90","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0047-6374(00)00199-8","volume":"121","author":"R Tarazona","year":"2000","unstructured":"Tarazona R, DelaRosa O, Alonso C et al (2000) Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector\/senescent T cells. Mech Ageing Dev 121:77\u201388","journal-title":"Mech Ageing Dev"},{"key":"361_CR91","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1167\/iovs.11-8377","volume":"53","author":"Z Tu","year":"2012","unstructured":"Tu Z, Li Y, Smith D et al (2012) Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 53:959\u2013966","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR92","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1034\/j.1600-0420.2000.078005536.x","volume":"78","author":"M Uusitalo","year":"2000","unstructured":"Uusitalo M, Mikkil\u00e4 H, Karma A et al (2000) Search for autoantibodies against the HNK-1 carbohydrate epitope in the human eye in intermediate uveitis. Acta Ophthalmol Scand 78:536\u2013538","journal-title":"Acta Ophthalmol Scand"},{"key":"361_CR93","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajo.2006.02.052","volume":"142","author":"B Kooij Van","year":"2006","unstructured":"Van Kooij B, Rothova A, Rijkers GT et al (2006) Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. Am J Ophthalmol 142:192\u2013194","journal-title":"Am J Ophthalmol"},{"key":"361_CR94","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1442-9071.1986.tb00034.x","volume":"14","author":"D Wakefield","year":"1986","unstructured":"Wakefield D, Dunlop I, McCluskey PJ et al (1986) Uveitis: aetiology and disease associations in an Australian population. Aust NZ J Ophthalmol 14:181\u2013187","journal-title":"Aust NZ J Ophthalmol"},{"key":"361_CR95","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/bjo.72.1.5","volume":"72","author":"RP Wetzig","year":"1988","unstructured":"Wetzig RP, Chan CC, Nussenblatt RB et al (1988) Clinical and immunopathological studies of pars planitis in a family. Br J Ophthalmol 72:5\u201310","journal-title":"Br J Ophthalmol"},{"key":"361_CR96","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archophthalmol.2009.32","volume":"127","author":"S Yeh","year":"2009","unstructured":"Yeh S, Li Z, Forooghian F et al (2009) CD4+Foxp3+\u00a0T-regulatory cells in noninfectious uveitis. Arch Ophthalmol 127:407\u2013413","journal-title":"Arch Ophthalmol"},{"key":"361_CR97","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000429631","volume":"23","author":"SL Yoser","year":"1992","unstructured":"Yoser SL, Forster DJ, Rao NA (1992) Pathology of intermediate uveitis. Dev Ophthalmol 23:60\u201370","journal-title":"Dev Ophthalmol"},{"key":"361_CR98","first-page":"3862","volume":"41","author":"M Yoshida","year":"2000","unstructured":"Yoshida M, Kezuka T, Streilein JW (2000a) Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells. Invest Ophthalmol Vis Sci 41:3862\u20133870","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR99","first-page":"811","volume":"41","author":"M Yoshida","year":"2000","unstructured":"Yoshida M, Takeuchi M, Streilein JW (2000b) Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Invest Ophthalmol Vis Sci 41:811\u2013821","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"361_CR100","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1167\/iovs.05-1267","volume":"47","author":"P Zamiri","year":"2006","unstructured":"Zamiri P, Masli S, Streilein JW et al (2006) Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation. Invest Ophthalmol Vis Sci 47:3912\u20133918","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-015-0361-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-015-0361-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-015-0361-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:48:33Z","timestamp":1704228513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-015-0361-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,5]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1007\/s00005-015-0361-y","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,5]]}}}